Literature DB >> 10460448

Outcome of central pontine and extrapontine myelinolysis (n = 44).

H Menger1, J Jörg.   

Abstract

The findings in 44 patients (42 of whom were chronic alcoholics) with central pontine myelinolysis show that the outcome does not depend on the severity of neurological deficits during the acute phase of the condition or on concomitant internal diseases, including the degree of hyponatremia. Of the 34 patients for whom follow-up data were available, 32 survived. Of these 11 completely recovered, 11 had some deficits but were independent, and 10 were dependent (4 through disorders of memory or cognition, 3 with tetraparesis, 2 with cerebellar ataxia, 1 with polyneuropathy). The electrophysiological findings did not contribute usefully to the prediction of outcome. Additional neuroradiological diagnostic testing with magnetic resonance imaging was also of no prognostic significance. The extent of the initial pontine lesion was not correlated with the severity of clinical findings during the acute phase of disease, nor was persistence of the pontine lesion as usually seen on magnetic resonance imaging correlated with clinical improvement. We conclude that patients with cerebral myelinolysis survive if the nonspecific secondary complications of transient illnesses such as aspiration pneumonia, ascending urinary tract infection with subsequent septicemia, deep venous thrombosis, and pulmonary embolism can be avoided.

Entities:  

Mesh:

Year:  1999        PMID: 10460448     DOI: 10.1007/s004150050435

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  50 in total

1.  Citalopram-induced hyponatraemia and parkinsonism: potentially fatal side-effects not to be missed.

Authors:  Negin Damali Amiri; Nishan Wijenaike
Journal:  BMJ Case Rep       Date:  2014-11-12

2.  Magnetic resonance imaging of sequelae of central pontine myelinolysis in chronic alcohol abusers.

Authors:  Akira Uchino; Takefumi Yuzuriha; Masaru Murakami; Koichi Endoh; Shigeto Hiejima; Hiroshi Koga; Sho Kudo
Journal:  Neuroradiology       Date:  2003-09-24       Impact factor: 2.804

Review 3.  Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes.

Authors:  R J Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

4.  Salt-free diet and pregnancy-related central pontine myelinolysis: "To diet or not?".

Authors:  Panos Ioannidis; George Balamoutsos; Dimitris Karacostas
Journal:  J Neurol       Date:  2010-07-20       Impact factor: 4.849

5.  Central pontine myelinolysis: electrolytes and beyond.

Authors:  J V Mascarenhas; E B Jude
Journal:  BMJ Case Rep       Date:  2014-03-28

Review 6.  Neurological counterparts of hyponatremia: pathological mechanisms and clinical manifestations.

Authors:  Manuel Alfredo Podestà; Irene Faravelli; David Cucchiari; Francesco Reggiani; Silvia Oldani; Carlo Fedeli; Giorgio Graziani
Journal:  Curr Neurol Neurosci Rep       Date:  2015-04       Impact factor: 5.081

7.  Plasmapheresis improves the outcome of central pontine myelinolysis.

Authors:  Daniela Grimaldi; Francesca Cavalleri; Stefano Vallone; Giorgio Milanti; Pietro Cortelli
Journal:  J Neurol       Date:  2005-03-02       Impact factor: 4.849

8.  Osmotic demyelination syndrome.

Authors:  Rachel Abbott; Eli Silber; Joerg Felber; Enefiok Ekpo
Journal:  BMJ       Date:  2005-10-08

9.  Advances in dialysis encephalopathy research: a review.

Authors:  Ying Chen; Xin Tian; Xuefeng Wang
Journal:  Neurol Sci       Date:  2018-05-02       Impact factor: 3.307

Review 10.  Preventing neurological complications from dysnatremias in children.

Authors:  Michael L Moritz; J Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2005-08-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.